Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC2 | Q9UIJ5 | 3/20 | 0.89 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.89 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.53 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | CASP2 | P42575 | 1/20 | 0.48 |
| ▸ | TGM2 | P21980 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 2/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.45 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL27724065 | 1.00 | ZDHHC2 (0.89) | ZDHHC2ZDHHC20EPHX1EGFRCASP2 | |
| Bicarbonate SCHEMBL8018968 | 0.94 | ZDHHC2 (0.92) | ZDHHC2ZDHHC20EPHX1EGFRCASP2 | |
| SCHEMBL890059 | 0.94 | ZDHHC20 (1.00) | ZDHHC2ZDHHC20EPHX1EGFRCASP2 | |
| SCHEMBL220516 | 0.94 | ZDHHC20 (1.00) | ZDHHC2ZDHHC20EPHX1EGFRCASP2 | |
| SCHEMBL14857206 | 0.94 | ZDHHC20 (1.00) | ZDHHC2ZDHHC20EPHX1EGFRCASP2 | |
| SCHEMBL346798 | 0.94 | ZDHHC20 (1.00) | ZDHHC2ZDHHC20EPHX1EGFRCASP2 | |
| SCHEMBL25793 | 0.94 | ZDHHC20 (1.00) | ZDHHC2ZDHHC20EPHX1EGFRCASP2 | |
| SCHEMBL17183678 | 0.94 | ZDHHC20 (1.00) | ZDHHC2ZDHHC20EPHX1EGFRCASP2 | |
| SCHEMBL426782 | 0.94 | ZDHHC20 (1.00) | ZDHHC2ZDHHC20EPHX1EGFRCASP2 | |
| SCHEMBL8087553 | 0.94 | ZDHHC20 (1.00) | ZDHHC2ZDHHC20EPHX1EGFRCASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543424-A2 | TOPICAL NAFTIFINE COMPOSITIONS | Taro Pharmaceutical Industries Ltd. (IL) | 2025-04-30 | — | — | EP | claimed |
| CN-119654144-A | Topical naftifine compositions | 塔罗制药工业有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119385986-A | Venturi effect preparation method of terbinafine film-forming composition | 江苏知原药业股份有限公司 | 2025-02-07 | — | — | CN | claimed |
| WO-2023250369-A2 | TOPICAL NAFTIFINE COMPOSITIONS | TARO PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2023-12-28 | — | — | WO | claimed |
| US-20230414537-A1 | TOPICAL NAFTIFINE COMPOSITIONS | TARO PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2023-12-28 | — | — | US | claimed |
| EP-1767183-A1 | METHOD OF HAIR RESTORATION, METHOD OF FIXATION AND STABILIZATION OF HAIR FOUNDATION AGENT, AND HAIR RESTORATION SETTING AGENT USED IN THE METHODS | Shimizu, Yoshikazu (JP) | 2007-03-28 | — | — | EP | claimed |
| US-6211250-B1 | CARRIERS AND HYDROPILIC POLYMERS | SOLTEC RESEARCH PTY LTD. (AU) | 2001-04-03 | — | — | US | claimed |
| EP-3838249-B1 | OIL-IN-WATER EMULSION COSMETIC COMPOSITION CONTAINING A CARBOXYLIC ACID MODIFIED SILICONE | DOW TORAY CO LTD (JP) | 2026-01-07 | — | — | EP | disclosed |
| US-12414977-B2 | Method of administering seaberry and saw palmetto extracts to inhibit 5α-reductase activity | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-09-16 | — | — | US | disclosed |
| US-20250268972-A1 | 5a-REDUCTASE INHIBITOR | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-08-28 | — | — | US | disclosed |
| EP-4543424-A2 | TOPICAL NAFTIFINE COMPOSITIONS | Taro Pharmaceutical Industries Ltd. (IL) | 2025-04-30 | — | — | EP | disclosed |
| EP-4543424-A2 | TOPICAL NAFTIFINE COMPOSITIONS | Taro Pharmaceutical Industries Ltd. (IL) | 2025-04-30 | — | — | EP | disclosed |
| CN-119654144-A | Topical naftifine compositions | 塔罗制药工业有限公司 | 2025-03-18 | — | — | CN | disclosed |
| EP-1767183-A1 | METHOD OF HAIR RESTORATION, METHOD OF FIXATION AND STABILIZATION OF HAIR FOUNDATION AGENT, AND HAIR RESTORATION SETTING AGENT USED IN THE METHODS | Shimizu, Yoshikazu (JP) | 2007-03-28 | — | — | EP | disclosed |
| US-6153179-A | A HAIR SETTING LOTION CONSISTS OF POLYVINYLCAPROLACTAM BLENDED WITH A FILM FORMING POLYMER SELECTED FROM AN ACYLATE COPOLYMERIZED WITH N-TERT-BUTYLACRYLAMIDE OR OCTYLACRYLAMIDE, A POLYURETHANE, VINYL ACETATE-MALEATE COPOLYMER | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-28 | — | — | US | disclosed |
| EP-0938290-A1 | SHAMPOO COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-01 | — | — | EP | disclosed |
| WO-1998004239-A2 | SHAMPOO COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-05 | — | — | WO | disclosed |
| WO-1998004241-A2 | SHAMPOO COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-05 | — | — | WO | disclosed |
| WO-1998004237-A1 | SHAMPOO COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-05 | — | — | WO | disclosed |
| WO-1994023696-A1 | CONDITIONING RINSE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 1994-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230414537-A1 | TOPICAL NAFTIFINE COMPOSITIONS | FLNA, DPM1, FLNB | ZDHHC2 1643/4885ZDHHC20 1748/4885EPHX1 3052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.